Global Branded Generics Market – Industry Trends and Forecast to 2028

  • Healthcare
  • Upcoming Report
  • Feb 2021
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global Branded Generics Market, By Product Type (Value-Added Branded Generics and Trade Named Generics), Therapeutic Application (Oncology, Cardiovascular Diseases, Diabetes, Neurology, Gastrointestinal Diseases, Dermatology Diseases, Analgesics and Anti-Inflammatory and Others), Drug Class (Alkylating Agents, Antimetabolites, Hormones, Anti-Hypertensive, Lipid Lowering Drugs, Anti-Depressants, Anti-Psychotics, Anti-Epileptic and Others), Consumption Type (Oral, Parenteral, Topical and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028

Branded Generics Market Market Analysis and Insights of Branded Generics Market

The rising need and demand for cheap medical treatment options coupled with pharmaceutical drugs, the branded generics market value is bound to rise. Data Bridge Market Research analyses that the branded generics market will exhibit a CAGR of around 7.53% for the forecast period of 2021-2028.

Branded generics are the re-released medicines or pharmaceutical drugs in the market with a different brand name. These are re-released at lower costs and even the shape, size colour and taste may vary though the drug is same. This is because the patent of that particular medicine or pharmaceutical drug has expired. To stay into the market and survive the competition, the drugs are re-released at lower costs which can be used to treat hypertension, diabetes, back pain, thyroid, and arthritis and so on. However, this must be carefully noted that even though there are certain changes made in re-releasing the drug, the quality remains the same. No compromises are made with the functions that the drug would perform.

The major reason responsible for the growth of branded generics is the rise in the number of expired patents. Upsurge in the patients with chronic and acute ailments too demand branded generics. Moreover, in the quest to land onto cheap and effective pharmaceutical drugs, they grow aware about the concept of branded generics. This in turn is also widening the scope of growth for the branded generics market.

However, stiff competition from the branded pharmaceutical drugs will pose a great challenge to branded generics market. Lack of penetration mechanisms will also dampen down the market growth rate.

This branded generics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on branded generics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Branded Generics Market Scope and Market Size

The branded generics market is segmented on the basis of product type, therapeutic application, drug class, consumption type and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • On the basis of product type, the branded generics are segmented into value-added branded generics and trade named generics.
  • On the basis of therapeutic application, the branded generics market is segmented into oncology, cardiovascular diseases, diabetes, neurology, gastrointestinal diseases, dermatology diseases, analgesics and anti-inflammatory and others.
  • On the basis of drug class, the branded generics market is segmented into alkylating agents, antimetabolites, hormones, anti-hypertensive, lipid lowering drugs, anti-depressants, anti-psychotics, anti-epileptic and others.
  • On the basis of consumption type, the branded generics market is segmented into oral, parental, topical and others.
  • The branded generics market is also segmented on the basis of hospital pharmacies, retail pharmacies, online pharmacies and others.

Branded Generics Market Country Level Analysis

The branded generics market is analysed and market size insights and trends are provided by country, product type, therapeutic application, drug class, consumption type and distribution channel as referenced above.

The countries covered in the branded generics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the branded generics market and will continue to undergo a significant rise in the market share during the forecast period. This is because of high demand and adoption of branded generics across countries in this region coupled with availability expert level healthcare facilities. Asia-Pacific on the other hand is projected to undergo the highest compound annual growth rate during this period owing to the rise in demand for cost effective medical or pharmaceutical drugs.

The country section of the branded generics market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Branded Generics Market Share Analysis

The branded generics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to branded generics market.

The major players covered in the branded generics market report are Zydus Cadila., Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Mylan N.V., Pfizer Inc., Bausch Health Companies Inc., Apotex Inc., GlaxoSmithKline plc., Sandoz International GmbH, Lupin Pharmaceuticals, Inc., Hetero., AstraZeneca, Novartis AG, Aspen Holdings, Eris Lifesciences Limited., Par Pharmaceutical., Sanofi, Sun Pharmaceutical Industries Ltd., Allergan and STADA Arzneimittel AG among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Customization Available : Global Branded Generics Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions